(Yicai Global) April 16 -- The AI cervical cancer diagnostic robot developed by a Chinese enterprise has been put into use in hundreds of medical institutions in China and has begun large-scale application to rural women's cervical cancer screening projects backed by local governments in four provinces, Yicai Global learned. It represents the first large-scale application of artificial intelligence technology in early diagnosis of cancer in China.
The robot developed by Wuhan Landing Medical High-Tech Co. has received clinical certifications and licenses from China, the US and the European Union, and has been put into practical use in China’s four provinces, namely the northern Shanxi province, central provinces of Hubei and Henan and the southern Yunnan province, reported the second-largest state-run news agency China News Service yesterday.
The robot can identify traces of cancer cells through digital images with extremely high efficiency. It can accurately identify precancerous and cancer cells, as well as normal cells, which makes it suitable for mass cancer screening, a representative from Chinese center for disease control and prevention told a conference on new progress in cervical cancer prevention and control held in Beijing recently.
“According to international regulations, cancer screening workers should read less than 100 samples per day to avoid diagnostic errors caused by excessive fatigue, but the robot is completely free from this limitation,” said the representative. “Based on previous laboratory performance, the robot has a maximum processing capacity of 1.08 million samples per month.”
The Hubei province identified Wuhan Landing Medical as a third-party inspection agency through open tendering to screen cervical cancer for 370,000 poor women of appropriate age in rural and urban areas across the province late last year in a massive campaign.
"Over the last few decades, China, like the majority of the world, has seen a steady decrease in deaths from cervical cancer, due in large part to screening efforts and improved treatment," said the Oncologist, the official journal of the Society for Translational Oncology, but added the disease still poses a significant threat to women.